Relation Between Topical Application of Platelet-Rich Plasma and Vancomycin and Severe Deep Sternal Wound Infections After a First Median Sternotomy

Dec 1, 2016 by in CARDIOLOGY Comments Off on Relation Between Topical Application of Platelet-Rich Plasma and Vancomycin and Severe Deep Sternal Wound Infections After a First Median Sternotomy

Deep sternal wound infections (DSWIs) are serious complications of sternotomy, leading to increased mortality and costs of care. Topical applications of autologous platelet concentrate and vancomycin have both shown promise…

read more

Left Ventricular Systolic Function Following Alcohol Septal Ablation for Symptomatic Hypertrophic Cardiomyopathy

Dec 1, 2016 by in CARDIOLOGY Comments Off on Left Ventricular Systolic Function Following Alcohol Septal Ablation for Symptomatic Hypertrophic Cardiomyopathy

Because alcohol septal ablation (ASA) for the treatment of symptomatic hypertrophic cardiomyopathy (HC) with left ventricular (LV) outflow tract (LVOT) obstruction results in a myocardial infarct of up to 10%…

read more

An Echocardiographic Measurement of Superior Vena Cava to Inferior Vena Cava Distance in Patients <20 Years of Age With Idiopathic Dilated Cardiomyopathy

Dec 1, 2016 by in CARDIOLOGY Comments Off on An Echocardiographic Measurement of Superior Vena Cava to Inferior Vena Cava Distance in Patients <20 Years of Age With Idiopathic Dilated Cardiomyopathy

In normal pediatric echocardiograms, the distance from the junction of superior vena cava (SVC) and right atrium to inferior vena cava (IVC) and right atrium is linearly related to height….

read more

Impact of the Preoperative Risk and the Type of Surgery on Exercise Capacity and Training After Valvular Surgery

Dec 1, 2016 by in CARDIOLOGY Comments Off on Impact of the Preoperative Risk and the Type of Surgery on Exercise Capacity and Training After Valvular Surgery

Information on exercise capacity and training in patients who underwent valvular surgery is scarce. The aim of this study is to evaluate postoperative exercise capacity and functional improvement after exercise…

read more

Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Severely Stenotic Bicuspid Versus Tricuspid or Nonbicuspid Valves

Dec 1, 2016 by in CARDIOLOGY Comments Off on Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Severely Stenotic Bicuspid Versus Tricuspid or Nonbicuspid Valves

Data on transcatheter aortic valve implantation (TAVI) for severe bicuspid aortic valve (BAV) stenosis and how this compares to that for tricuspid aortic valve (TAV) stenosis are limited. Twenty-one consecutive…

read more

Left Atrial Remodeling in Hypertrophic Cardiomyopathy and Susceptibility Markers for Atrial Fibrillation Identified by Cardiovascular Magnetic Resonance

Dec 1, 2016 by in CARDIOLOGY Comments Off on Left Atrial Remodeling in Hypertrophic Cardiomyopathy and Susceptibility Markers for Atrial Fibrillation Identified by Cardiovascular Magnetic Resonance

In hypertrophic cardiomyopathy (HC), atrial fibrillation (AF) is an important determinant of clinical deterioration due to heart failure or embolic stroke. This study characterizes left atrial (LA) structural and functional…

read more

Impact of High-Dose Atorvastatin Therapy and Clinical Risk Factors on Incident Aortic Valve Stenosis in Patients With Cardiovascular Disease (from TNT, IDEAL, and SPARCL)

Dec 1, 2016 by in CARDIOLOGY Comments Off on Impact of High-Dose Atorvastatin Therapy and Clinical Risk Factors on Incident Aortic Valve Stenosis in Patients With Cardiovascular Disease (from TNT, IDEAL, and SPARCL)

Clinical trials have not provided evidence for a role of statin therapy in reducing aortic valve stenosis (AVS) severity in patients with documented AVS. However, whether statin therapy could prevent…

read more

Safety of Short-Term Use of Dabigatran or Rivaroxaban for Direct-Current Cardioversion in Patients With Atrial Fibrillation and Atrial Flutter

Dec 1, 2016 by in CARDIOLOGY Comments Off on Safety of Short-Term Use of Dabigatran or Rivaroxaban for Direct-Current Cardioversion in Patients With Atrial Fibrillation and Atrial Flutter

Direct-current cardioversion (DCCV) for persistent atrial fibrillation or atrial flutter (AF) carries a risk of thromboembolic events (TEs). Therapeutic anticoagulation with warfarin is recommended for 3 to 4 weeks before and…

read more
Get Clinical Tree app for offline access